Safety and efficacy of generic nab-paclitaxel-based therapy in Chinese patients with malignant tumors in a real-world setting: a multicenter prospective observational study

Authors

Qiongshi Wu
Guangxuan Liu
Donghang Xu (ORCID: https://orcid.org/0000-0001-5502-426X)
Mei Dong (ORCID: https://orcid.org/0000-0001-5673-3359)
Kanghuai Zhang
Zaixian Bai
Jiang Liu (ORCID: https://orcid.org/0000-0001-8885-4374)
Guohui Li (ORCID: https://orcid.org/0000-0002-1739-4048)
Weiyi Feng (ORCID: https://orcid.org/0000-0003-0581-6773)
Yancai Sun
Zhiying Hao
Fei He (ORCID: https://orcid.org/0000-0002-9119-9056)
Wenzhou Zhang (ORCID: https://orcid.org/0000-0001-7112-392X)

Institutions

Hebei Medical University (CN)
University of Science and Technology of China (CN)
Harbin Medical University (CN)
Shanxi Medical University (CN)
Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
National Cancer Center (US)
Third Affiliated Hospital of Harbin Medical University (CN)
Fourth Hospital of Hebei Medical University (CN)
First Affiliated Hospital of Xi'an Jiaotong University (CN)
Hainan General Hospital (CN)
Second Affiliated Hospital of Xi'an Jiaotong University (CN)
Henan Cancer Hospital (CN)
Second Affiliated Hospital of Zhejiang University (CN)
Liaoning Cancer Hospital & Institute (CN)
Inner Mongolia Medical University (CN)
Xi'an Jiaotong University (CN)

Publication Details

Journal: Discover Oncology
Published: 2024-11-26
DOI: https://doi.org/10.1007/s12672-024-01609-6
Citations: 2
Primary Topic: Cancer Treatment and Pharmacology
Type: article
Field-Weighted Citation Impact: 0.57

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Safety and efficacy of generic nab-paclitaxel-based therapy in Chinese patients with malignant tumors in a real-world setting: a multicenter prospective observational study

Qiongshi Wu, Guangxuan Liu, Donghang Xu, Mei Dong et al.

Nov 26, 2024

2 citations

Discover Oncology

Cancer Treatment and Pharmacology

0.57

article

Safety and efficacy of generic nab-paclitaxel-based therapy in Chinese patients with malignant tumors in a real-world setting: a multicenter prospective observational study

Qiongshi Wu, Guangxuan Liu, Donghang Xu, Mei Dong, Kanghuai Zhang, Zaixian Bai, Jiang Liu, Guohui Li, Weiyi Feng, Yancai Sun, Zhiying Hao, Fei He, Wenzhou Zhang

November 26, 2024article en

2 citations

Abstract

No abstract available for this paper.

Discover OncologyVol. 15(1)

Hebei Medical University (CN), University of Science and Technology of China (CN), Harbin Medical University (CN), Shanxi Medical University (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), National Cancer Center (US), Third Affiliated Hospital of Harbin Medical University (CN), Fourth Hospital of Hebei Medical University (CN), First Affiliated Hospital of Xi'an Jiaotong University (CN), Hainan General Hospital (CN), Second Affiliated Hospital of Xi'an Jiaotong University (CN), Henan Cancer Hospital (CN), Second Affiliated Hospital of Zhejiang University (CN), Liaoning Cancer Hospital & Institute (CN), Inner Mongolia Medical University (CN), Xi'an Jiaotong University (CN)

Good health and well-being

Openalex Percentile: Top 26%

Cancer Treatment and Pharmacology

0.57

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Safety and efficacy of generic nab-paclitaxel-based therapy in Chinese patients with malignant tumors in a real-world setting: a multicenter prospective observational study — Qiongshi Wu, Guangxuan Liu, et al. · Discover Oncology (2024) | TGRS Research Map | TGRS